Do Laboratory Biomarkers Predict Survival In Severe Covid-19? A Cross-Sectional Study

Sher Bahadur1, Fawad Rahim2, Said Amin2

  • 1Khyber Institute of Child Health, Medical Teaching Institute / Hayatabad Medical Complex, Peshawar.

Insights

In severe COVID-19, elevated C-reactive protein (CRP) and Lactate Dehydrogenase (LDH) levels predict survival. However, lymphopenia and increased D-dimers may not indicate poor outcomes.

Area of Science:

  • Biochemistry
  • Immunology
  • Critical Care Medicine

Background:

  • Severe COVID-19 is associated with significant inflammatory markers.
  • Understanding the prognostic value of various biomarkers is crucial for patient management.

Purpose of the Study:

  • To compare key biomarkers including lymphocyte count, C-reactive protein (CRP), ferritin, Lactate Dehydrogenase (LDH), and D-dimer between survivors and non-survivors of severe COVID-19.
  • To evaluate the predictive value of these biomarkers for survival in severe COVID-19 patients.

Main Methods:

  • Retrospective cross-sectional study of 69 severe COVID-19 patients with available biomarker and survival data.
  • Analysis included baseline and peak/trough values for CRP, ferritin, LDH, D-dimer, and lymphocyte counts.
  • Biomarker comparisons between survivors and non-survivors were performed using paired t-tests, with statistical significance set at p < 0.05.

Main Results:

  • Significant increases in C-reactive protein (CRP) and Lactate Dehydrogenase (LDH) were observed in non-survivors but not in survivors.
  • Both groups showed significant decreases in lymphocyte counts and significant increases in D-dimer levels.
  • Serum ferritin levels did not show significant elevation in either group.

Conclusions:

  • Serum CRP and LDH levels are valuable for risk stratification and predicting survival in severe COVID-19.
  • Lymphopenia, elevated serum ferritin, and increased D-dimers may not be reliable predictors of survival in this patient population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
229
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
138
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
247
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20